MedTrace Logo

Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis

NCT00361439 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2014-02-28

Study results available
· View outcomes & findings →

Summary

People with allergies frequently complain of a loss or reduction in the sense of smell.

In this study, the investigators propose to perform a randomized, double blind, placebo controlled parallel study of subjects with nasal allergies and decreased smell to determine the effect of a treatment for allergies on the sense of smell.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

DRUG

Mometasone

2 puffs in each nostril once daily of nasal spray

DRUG

Placebo

2 puffs in each nostril once daily of nasal spray

Sponsors & Collaborators

  • Schering-Plough

    collaborator INDUSTRY

  • University of Chicago

    lead OTHER

Principal Investigators

  • Jayant M Pinto, MD · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00361439 on ClinicalTrials.gov